FindTrial
Sign In

TIMING OF OESOPHAGECTOMY AFTER NEOADJUVANT CHEMORADIOTHERAPY FOR LOCALLY ADVANCED OESOPHAGEAL CANCER

TIMING OF OESOPHAGECTOMY AFTER NEOADJUVANT CHEMORADIOTHERAPY FOR LOCALLY ADVANCED OESOPHAGEAL CANCER

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200059906
Enrollment
Unknown
Registered
2022-05-13
Start date
2022-05-01
Completion date
Unknown
Last updated
2024-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

chemoradiation group:chemoradiation

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Pathologically confirmed esophageal squamous cell carcinoma or adenocarcinoma; 2. Thoracic and abdominal enhanced CT, pulmonary function, electrocardiogram and other examinations were performed to confirm that there was no contraindication for operation; 3. Preoperative neoadjuvant therapy (radiotherapy/chemotherapy/immunotherapy); 4. The clinical and pathological data are complete.

Exclusion criteria

Exclusion criteria: 1. The tumor cannot be removed or not completely removed during operation; 2. Have a history of stomach surgery or cannot perform stomach replacement surgery.

Design outcomes

Primary

MeasureTime frame
Complications;Anastomotic complications;1-yr,2-yr,3yr survival;1-yr,2-yr,3yr disease-free survival;—

Secondary

MeasureTime frame
Thoracic gastric dilatation;Gastroesophageal anastomosis width;—

Countries

China

Contacts

Public ContactYong Yuan

West China Hospital of Sichuan University

yongyuan@scu.edu.cn+86 18980606739

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026